Login / Signup

Management and outcomes in secondary diabetes among pediatric patients hospitalized with hemophagocytic lymphohistiocytosis.

Cintya SchweisbergerNila PalaniappanNicole M WoodLauren E AmosKelsee L Halpin
Published in: Journal of pediatric endocrinology & metabolism : JPEM (2023)
One-third of hospitalized pediatric patients with HLH developed secondary diabetes requiring insulin therapy. Insulin is typically started within 5 days of initiating steroids, limited to IV infusions, and often is not needed by discharge. Secondary diabetes was associated with longer ICU stays and heightened risk of intubation.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • intensive care unit
  • insulin resistance
  • weight loss
  • stem cells
  • mesenchymal stem cells
  • metabolic syndrome
  • smoking cessation
  • bone marrow